Vijaya B Kolachalama

Summary

Affiliation: Massachusetts Institute of Technology
Country: USA

Publications

  1. ncbi Predictive haemodynamics in a one-dimensional human carotid artery bifurcation. Part I: Application to stent design
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA
    IEEE Trans Biomed Eng 54:802-12. 2007
  2. ncbi Mining data from hemodynamic simulations via Bayesian emulation
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA
    Biomed Eng Online 6:47. 2007
  3. ncbi Predictive haemodynamics in a one-dimensional human carotid artery bifurcation. Part II: Application to graft design
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA
    IEEE Trans Biomed Eng 55:1176-84. 2008
  4. ncbi Luminal flow patterns dictate arterial drug deposition in stent-based delivery
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
    J Control Release 133:24-30. 2009
  5. ncbi Luminal flow amplifies stent-based drug deposition in arterial bifurcations
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
    PLoS ONE 4:e8105. 2009
  6. ncbi Lesion complexity determines arterial drug distribution after local drug delivery
    Abraham R Tzafriri
    Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    J Control Release 142:332-8. 2010
  7. ncbi Performance and scaling effects in a multilayer microfluidic extracorporeal lung oxygenation device
    Tatiana Kniazeva
    Draper Laboratory, 555 Technology Square, Cambridge, MA, USA
    Lab Chip 12:1686-95. 2012
  8. ncbi Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings
    Kumaran Kolandaivelu
    77 Massachusetts Ave, Cambridge, MA 02139, USA
    Circulation 123:1400-9. 2011

Collaborators

Detail Information

Publications8

  1. ncbi Predictive haemodynamics in a one-dimensional human carotid artery bifurcation. Part I: Application to stent design
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA
    IEEE Trans Biomed Eng 54:802-12. 2007
    ..In particular, it is found that localized pressure peaks do not depend on the length of a stent. Finally, we demonstrate how these metrics may be applied to cost-effectively predict the benefit of stenting...
  2. ncbi Mining data from hemodynamic simulations via Bayesian emulation
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA
    Biomed Eng Online 6:47. 2007
    ..Finally, potential diagnostic indicators were proposed that can be used to aid the assessment of stroke risk for a given patient's geometry...
  3. ncbi Predictive haemodynamics in a one-dimensional human carotid artery bifurcation. Part II: Application to graft design
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA
    IEEE Trans Biomed Eng 55:1176-84. 2008
    ..5%, 80%, 85%, and 90% stenosis in the ICA, respectively...
  4. ncbi Luminal flow patterns dictate arterial drug deposition in stent-based delivery
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA
    J Control Release 133:24-30. 2009
    ..Coronary drug-eluting stents should be appropriately considered where luminal flow, strut design and pulsatility have direct effects on tissue drug uptake after local delivery...
  5. ncbi Luminal flow amplifies stent-based drug deposition in arterial bifurcations
    Vijaya B Kolachalama
    Biomedical Engineering Center, Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
    PLoS ONE 4:e8105. 2009
    ....
  6. ncbi Lesion complexity determines arterial drug distribution after local drug delivery
    Abraham R Tzafriri
    Harvard MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    J Control Release 142:332-8. 2010
    ....
  7. ncbi Performance and scaling effects in a multilayer microfluidic extracorporeal lung oxygenation device
    Tatiana Kniazeva
    Draper Laboratory, 555 Technology Square, Cambridge, MA, USA
    Lab Chip 12:1686-95. 2012
    ..These results contribute to our understanding of the complexity involved in designing three-dimensional microfluidic oxygenators for clinical applications...
  8. ncbi Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings
    Kumaran Kolandaivelu
    77 Massachusetts Ave, Cambridge, MA 02139, USA
    Circulation 123:1400-9. 2011
    ..Stent thrombosis is a lethal complication of endovascular intervention. Concern has been raised about the inherent risk associated with specific stent designs and drug-eluting coatings, yet clinical and animal support is equivocal...